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TO THE EDITOR
Filaggrin is a key protein required for
the formation of the stratum corneum
(SC) barrier. Filaggrin is also essential
for SC hydration, as it acts as a source of
hygroscopic amino acids and their
derivatives, known as natural moistur-
izing factor (NMF).
The human gene encoding filaggrin
(FLG) is highly polymorphic and to
date, 15 null mutations have been
detected of which four (R501X,
2282del4, R2447X, and S3247X)
are prevalent at varying frequencies in
the white European population (Sandi-
lands et al., 2007). Homozygous or
compound heterozygous FLG muta-
tions underlie the common skin-kerati-
nizing disorder ichthyosis vulgaris, and
have been shown to be a major genetic
predisposing factor for atopic dermatitis
(AD) (Sandilands et al., 2006).
Diminished filaggrin expression has
been demonstrated in both ichthyosis
vulgaris and AD skin (Seguchi et al.,
1996; Sugiura et al., 2005; Smith et al.,
2006).
As filaggrin is the precursor protein
for the amino-acid-derived components
of the NMF, we hypothesized that
carriers of FLG-null mutations have
reduced level of NMF in the SC.
To measure NMF in the SC of the
palm (thenar eminence) and forearm
skin, we used confocal Raman micro-
spectroscopy (3510 Skin Composition
Analyzer; River Diagnostics, Rotter-
dam, The Netherlands). The principles
of this method and the procedure have
extensively been described elsewhere
(Caspers et al., 2001, 2003). The
reference spectrum of NMF was con-
structed from a superposition of the
spectra of pyrrolidone-5-carboxylic
acid, ornithine, serine, proline, glycine,
histidine, and alanine.
In addition to NMF, skin barrier
function as measured by transepidermal
water loss was assessed on the volar
forearm (Tewameter 210; Courage and
Khazaka Electronic GmbH, Cologne,
Germany).
One hundred and forty-nine volun-
teers recruited by public advertisement,
as well as 10 AD patients, were
screened for four FLG mutations
(R501X, 2282del4 R2447X, and
S3247X). All subjects filled in a ques-
tionnaire on the history of skin diseases
and allergies, and the Erlangen atopy
questionnaire that also included a
question on skin dryness. Signs of active
disease (erythema, crusting, weeping,
and lichenification) were assessed by a
dermatologist. Having visible skin
changes on the forearm was the exclu-
sion criterion. Written informed con-
sent was obtained from all subjects. The
experimental protocol followed the
Declaration of Helsinki Principles and
was approved by the Ethical Committee
of the Academic Medical Centre.
Genomic DNA was extracted from
buccal swab samples (Puregenes
DNA isolation kit; Gentra Systems,
Minneapolis, MN). Polymorphisms
were genotyped as reported previously
(Sandilands et al., 2007). To compare
data from two groups, we used two-
tailed Student’s t-test for unpaired
samples.
Sixteen carriers (12 female) of an
FLG mutation and 23 individuals
(15 female) wild type with respect to
these mutations were included in
the study. Of the 16 carriers, five
were heterozygous for R501X, eight
were heterozygous for 2282del4, and
one was heterozygous for R2447X.
One individual was homozygous for
Abbreviations: AD, atopic dermatitis; FLG, human filaggrin-encoding gene; NMF, natural moisturizing
factor; SC, stratum corneum
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2282del4 and one individual was com-
pound heterozygous for R501X and
2282del4. The mean age of the carrier
group was 33 years (range 20–55 years),
which was comparable with that of
non-carriers (mean 30, range 20–61
years). The prevalence of AD history
and active AD was higher in carriers of
an FLG mutation (Figure 1). Further, all
carriers and 11 non-carriers reported
having a dry skin.
In this study, we have demonstrated
that individuals who are carriers of
FLG-null mutations have significantly
reduced levels of NMF in the SC on
both skin locations and at all SC depths
(Figures 1 and 2). Palmar skin showed
less interindividual differences in NMF
levels as compared with forearm skin
(Figure 1). FLG carriers who had signs
of active disease (n¼ 4) did not have
NMF values different from those in
individuals without active AD (both
skin locations P40.1), although we
acknowledge that the size of groups
are small. Also a history of AD did not
result in different NMF levels within
both groups (P40.1). Furthermore, FLG
carriers with a history of AD had
significantly lower NMF level than
non-carriers with a history of AD
(Po0.0001). Two individuals who were
homozygous and compound hetero-
zygous for investigated FLG mutations
showed lower NMF levels than the
group averages (Figure 1).
Although clear difference was found
in NMF content between carriers and
non-carriers of FLG mutations, it has to
be realized that NMF content is depen-
dent on several factors and not only on
the FLG genotype (Rawlings and Matts,
2005). The breakdown of filaggrin is
under control of proteolytic enzymes
and is influenced by the hydration
gradient across the skin that is depen-
dent on the external humidity and the
transepidermal water loss. The latter
factor is influenced by the quality of the
skin barrier, primarily by the composi-
tion and structure of the lipid bilayers.
There are also other possible genetic
modifiers of the effect of FLG muta-
tions, which are plausibly involved in
controlling filaggrin processing, includ-
ing SPINK5 and SCCE (Sandilands
et al., 2007). In addition, a heterozy-
gote for a loss-of-function mutation
might carry an expanded exon 3 on
the other allele, lessening the overall
effect of the mutation (Smith et al.,
2006). Furthermore, it has recently
been reported that filaggrin skin expres-
sion could be modulated by the atopic
inflammatory response mediated by
cytokines IL-4 and IL-13 (Howell
et al., 2007).
In addition to reduced levels of
NMF, carriers of FLGmutations showed
a higher transepidermal water loss as
compared with non-carriers (10.3±2.7
and 8.3±2.2 g hm2, respectively;
P¼0.01). The literature data on transe-
pidermal water loss in AD patients is
contradictory, and this inconsistency
might, at least partly, be explained by
different phenotypes of AD patients.
Given that approximately 50% of mod-
erate-to-severe AD patients may be
carriers of an FLG-null mutation, it has
been speculated that FLG status may
define a subtype of barrier-related AD.
Since polymorphisms in the FLG gene
lead to reduced amount of filaggrin and
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FLG loss-of-function mutation. Relative NMF concentration is expressed as the NMF/keratin ratio in arbitrary units.
Forearm skin Palmar skin
1
0
1
0
Carriers
Non-carriers
Carriers
Non-carriers
R
el
at
iv
e 
N
M
F 
co
nc
en
tra
tio
n
R
el
at
iv
e 
N
M
F 
co
nc
en
tra
tio
n
0 5 10 15 20 25 25 30 35 40 45 50 55
SC depth (μm) SC depth (μm)
Figure 2. Relative NMF concentration (mean±SD) measured at different SC depths on the forearm and palm of carriers and non-carriers of
FLG loss-of-function mutations. Relative NMF concentration is expressed as the NMF/keratin ratio in arbitrary units.
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consequently to a decreased level of
NMF, measurement of NMF could
improve classification of AD pheno-
types. Identification of this measurable
physical parameter as a marker of FLG
status could enable more targeted pre-
vention of AD in susceptible individuals.
Measurement of the NMF phenotype
in particular by in vivo Raman spectro-
scopy, is much less demanding
then genotyping. This initial study
shows some highly promising results.
Sensitivity and specificity of this meth-
od will be further investigated in
larger, well-defined study groups to
explore its potential usefulness in clini-
cal practice.
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TO THE EDITOR
Allergic contact dermatitis (ACD) is a
frequent T-cell-mediated inflammatory
skin disease in response to skin expo-
sure to non-protein chemicals, called
haptens. Development of ACD pro-
ceeds in two phases (Saint-Mezard
et al., 2004). The sensitization (afferent)
phase, induced by the migration of
hapten-loaded skin dendritic cells
(DCs) to draining lymph nodes, leads
to the priming of hapten-specific effec-
tor T cells. The elicitation (efferent)
phase, generated on skin re-exposure
to the same hapten, induces the recruit-
ment of T cells into the skin resulting in
ACD through IFN-g production and
cytotoxicity toward keratinocytes.
Allergic contact dermatitis is a major
public health concern in industrialized
countries, and there is an urgent need
for tests allowing for detection of
potentially allergenic compounds manu-
factured by industries (Diepgen and
Kanerva, 2006; Williams et al., 2006).
Predictive testing for the sensitizing
properties of haptens has been tradi-
tionally carried out in guinea pigs and
mice (Gerberick et al., 2007; Maurer,
2007). More recently, alternative
in vitro methods have been developed
to test the ability of haptens to prime
naive peripheral blood T cells. These
assays, referred to as primary sensiti-
zation assays, consist of an auto-
logous mixed DC–lymphocyte reaction
(MDLR) using hapten-loaded DCs as
antigen-presenting cells and normal
human peripheral blood leucocytes
(PBLs) as responding cells. In vitro
priming of hapten-specific T cells was
usually assessed by cell proliferation
Abbreviations: ACD, allergic contact dermatitis; DC, dendritic cell; MDLR, mixed DC–lymphocyte
reaction; PBL, peripheral blood lymphocyte
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